• Non-Credit Course
  • Advanced Practice Provider
Mary Peavey, MD, MSc, will provide an overview of the fertility preservation options available to male and female patients receiving treatment at UNC hospitals.
  • 1.00 Participation
  • Non-Credit Course
  • Advanced Practice Provider
Exploration of diet related factors that may affect patient response to anti-cancer immunotherapy.
  • 1.00 Participation
  • Non-Credit Course
  • Patient Centered Care
  • Southeastern American Indian Cancer Health Equity Partnership
Ronny Bell, PhD, MS, and Marc Emerson, PhD, MPH, in this collaborative session will provide context regarding the cancer disparities and efforts to address these disparities
  • 1.00 Participation
  • Non-Credit Course
  • Advanced Practice Provider
This will be an interactive, introductory session on computed tomography with an emphasis on anatomy and common oncology findings.
  • 1.00 Participation
  • Non-Credit Course
  • Southeastern American Indian Cancer Health Equity Partnership
Rodney Haring, PhD, MSW, will discuss how treaty and wampum conversations have impacted the cancer care of Indigenous populations. Building on this foundation, Dr.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Dr.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicul
  • 1.00 Participation
  • Non-Credit Course
  • Advanced Practice Provider
Webinar DescriptionBrian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targete
  • 1.00 Participation
  • Non-Credit Course
  • Southeastern American Indian Cancer Health Equity Partnership
Webinar DescriptionHannah E.
  • 1.00 Participation
  • Non-Credit Course
  • Patient Centered Care
Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatme
  • 1.00 Participation

Pages